A detailed history of Envestnet Asset Management Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 158,170 shares of PACB stock, worth $253,072. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158,170
Previous 116,378 35.91%
Holding current value
$253,072
Previous $159,000 68.55%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$1.2 - $2.17 $50,150 - $90,688
41,792 Added 35.91%
158,170 $268,000
Q2 2024

Aug 08, 2024

SELL
$1.36 - $3.65 $12,415 - $33,320
-9,129 Reduced 7.27%
116,378 $159,000
Q1 2024

May 13, 2024

SELL
$3.52 - $9.59 $12,397 - $33,775
-3,522 Reduced 2.73%
125,507 $470,000
Q4 2023

Feb 13, 2024

BUY
$5.97 - $10.36 $453,063 - $786,220
75,890 Added 142.81%
129,029 $1.27 Million
Q3 2023

Nov 13, 2023

BUY
$8.23 - $13.93 $153,053 - $259,056
18,597 Added 53.84%
53,139 $443,000
Q2 2023

Aug 04, 2023

BUY
$9.97 - $14.05 $99,061 - $139,600
9,936 Added 40.38%
34,542 $459,000
Q1 2023

May 11, 2023

BUY
$7.94 - $12.02 $9,829 - $14,880
1,238 Added 5.3%
24,606 $284,000
Q4 2022

Feb 07, 2023

BUY
$5.67 - $11.2 $9,168 - $18,110
1,617 Added 7.43%
23,368 $191,000
Q3 2022

Nov 10, 2022

BUY
$3.93 - $8.57 $1,583 - $3,453
403 Added 1.89%
21,751 $126,000
Q2 2022

Aug 03, 2022

BUY
$4.02 - $10.43 $7,621 - $19,775
1,896 Added 9.75%
21,348 $94,000
Q1 2022

May 04, 2022

SELL
$8.43 - $20.9 $4,830 - $11,975
-573 Reduced 2.86%
19,452 $177,000
Q4 2021

Feb 04, 2022

BUY
$19.26 - $30.08 $385,681 - $602,352
20,025 New
20,025 $410,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $360M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.